Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 130

1.

Vaccination with clumping factor A and fibronectin binding protein A to prevent Staphylococcus aureus infection of an aortic patch in mice.

Arrecubieta C, Matsunaga I, Asai T, Naka Y, Deng MC, Lowy FD.

J Infect Dis. 2008 Aug 15;198(4):571-5. doi: 10.1086/590210.

2.

Vaccination against Staphylococcus aureus experimental endocarditis using recombinant Lactococcus lactis expressing ClfA or FnbpA.

Veloso TR, Mancini S, Giddey M, Vouillamoz J, Que YA, Moreillon P, Entenza JM.

Vaccine. 2015 Jul 9;33(30):3512-7. doi: 10.1016/j.vaccine.2015.05.060. Epub 2015 Jun 3.

PMID:
26048778
3.

Targeting Alpha Toxin and ClfA with a Multimechanistic Monoclonal-Antibody-Based Approach for Prophylaxis of Serious Staphylococcus aureus Disease.

Tkaczyk C, Hamilton MM, Sadowska A, Shi Y, Chang CS, Chowdhury P, Buonapane R, Xiao X, Warrener P, Mediavilla J, Kreiswirth B, Suzich J, Stover CK, Sellman BR.

MBio. 2016 Jun 28;7(3). pii: e00528-16. doi: 10.1128/mBio.00528-16.

4.

Protection against experimental Staphylococcus aureus arthritis by vaccination with clumping factor A, a novel virulence determinant.

Josefsson E, Hartford O, O'Brien L, Patti JM, Foster T.

J Infect Dis. 2001 Dec 15;184(12):1572-80. Epub 2001 Dec 3.

PMID:
11740733
5.

Protective immunization against Staphylococcus aureus infection in a novel experimental wound model in mice.

Schennings T, Farnebo F, Szekely L, Flock JI.

APMIS. 2012 Oct;120(10):786-93. doi: 10.1111/j.1600-0463.2012.02907.x. Epub 2012 May 7.

PMID:
22958286
6.

Preclinical Efficacy of Clumping Factor A in Prevention of Staphylococcus aureus Infection.

Li X, Wang X, Thompson CD, Park S, Park WB, Lee JC.

MBio. 2016 Feb 2;7(1):e02232-15. doi: 10.1128/mBio.02232-15.

7.
8.

Fibrinogen and fibronectin binding cooperate for valve infection and invasion in Staphylococcus aureus experimental endocarditis.

Que YA, Haefliger JA, Piroth L, François P, Widmer E, Entenza JM, Sinha B, Herrmann M, Francioli P, Vaudaux P, Moreillon P.

J Exp Med. 2005 May 16;201(10):1627-35.

9.

Demonstration of the preclinical correlate of protection for Staphylococcus aureus clumping factor A in a murine model of infection.

Scully IL, Timofeyeva Y, Keeney D, Matsuka YV, Severina E, McNeil LK, Nanra J, Hu G, Liberator PA, Jansen KU, Anderson AS.

Vaccine. 2015 Oct 5;33(41):5452-7. doi: 10.1016/j.vaccine.2015.08.029. Epub 2015 Aug 28.

10.

Immunization with Staphylococcus aureus clumping factor B, a major determinant in nasal carriage, reduces nasal colonization in a murine model.

Schaffer AC, Solinga RM, Cocchiaro J, Portoles M, Kiser KB, Risley A, Randall SM, Valtulina V, Speziale P, Walsh E, Foster T, Lee JC.

Infect Immun. 2006 Apr;74(4):2145-53.

11.

Characterization of a protective monoclonal antibody recognizing Staphylococcus aureus MSCRAMM protein clumping factor A.

Hall AE, Domanski PJ, Patel PR, Vernachio JH, Syribeys PJ, Gorovits EL, Johnson MA, Ross JM, Hutchins JT, Patti JM.

Infect Immun. 2003 Dec;71(12):6864-70.

12.

Identification of the immunodominant regions of Staphylococcus aureus fibronectin-binding protein A.

Zuo QF, Cai CZ, Ding HL, Wu Y, Yang LY, Feng Q, Yang HJ, Wei ZB, Zeng H, Zou QM.

PLoS One. 2014 Apr 15;9(4):e95338. doi: 10.1371/journal.pone.0095338. eCollection 2014.

14.

Vaccination with a recombinant fragment of collagen adhesin provides protection against Staphylococcus aureus-mediated septic death.

Nilsson IM, Patti JM, Bremell T, Höök M, Tarkowski A.

J Clin Invest. 1998 Jun 15;101(12):2640-9.

15.

The role of Staphylococcus aureus adhesins in the pathogenesis of ventricular assist device-related infections.

Arrecubieta C, Asai T, Bayern M, Loughman A, Fitzgerald JR, Shelton CE, Baron HM, Dang NC, Deng MC, Naka Y, Foster TJ, Lowy FD.

J Infect Dis. 2006 Apr 15;193(8):1109-19. Epub 2006 Mar 2.

PMID:
16544251
16.

Construction of scFv that bind both fibronectin-binding protein A and clumping factor A of Stapylococcus aureus.

Wang M, Zhang Y, Li B, Zhu J.

Res Vet Sci. 2015 Jun;100:109-14. doi: 10.1016/j.rvsc.2015.02.012. Epub 2015 Apr 7.

PMID:
25910693
17.

Synthesis and evaluation of a conjugate vaccine composed of Staphylococcus aureus poly-N-acetyl-glucosamine and clumping factor A.

Maira-Litrán T, Bentancor LV, Bozkurt-Guzel C, O'Malley JM, Cywes-Bentley C, Pier GB.

PLoS One. 2012;7(9):e43813. doi: 10.1371/journal.pone.0043813. Epub 2012 Sep 6.

18.
19.
20.

Role of interleukin-17A in cell-mediated protection against Staphylococcus aureus infection in mice immunized with the fibrinogen-binding domain of clumping factor A.

Narita K, Hu DL, Mori F, Wakabayashi K, Iwakura Y, Nakane A.

Infect Immun. 2010 Oct;78(10):4234-42. doi: 10.1128/IAI.00447-10. Epub 2010 Aug 2.

Supplemental Content

Support Center